Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer

Cancer Research

Volumn 60, Issue 12, 2000, Pages 3155-3159

  Ahrendt, Steven A ^b   Chow, John T ^a   Yang, Stephen C ^a   Wu, Li ^a   Zhang, Mei Jie ^b   Jen, Jin ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL MODEL;

AGED; ALCOHOL DRINKING; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SMOKING;

EID: 0034124449     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Landis, S., Murray, T., Bolden, S., and Wingo, P. Cancer Statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
2. Carbone, D. Smoking and cancer. Am. J. Med., 93: 13-17, 1992.
3. Shopland, D. R., Eyre, H. J., and Pechacek, T. F. Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? J. Natl. Cancer Inst., 83: 1142-1148, 1991.
4. Carpenter, C., Morgenstern, H., and London, S. Alcoholic beverage consumption and lung cancer risk among residents of Los Angeles County. J. Nutr., 128: 694-700. 1998.
5. Spitz, M. R., Shi, H., Yang, F., Hudmon, K. S., Jiang, H., Chamberlain, R. M., Amos, C. I., Wan, Y., Cinciripini, P., Hong, W. K., and Wu, X. Case-control study of D2 dopamine receptor gene and smoking status in lung cancer patients. J. Natl. Cancer Inst., 90: 358-363, 1998.
6. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass A., Keogh, J. P., Meyskens, F. L. Jr., Valanis, B., Williams J. H. Jr, Barnhart, S., Cherniack, M. G., Brodkin, C. A., and Hammar, S. Risk factors for lung cancer and for intervention effects in CARET, the β-Carotene and Retinol Efficacy Trial. J. Natl. Cancer Inst., 88: 1550-1559, 1996.
7. De Stefani, E., Correa, P., Fierro, L., Fontham, E. T., Chen, V., and Zavala, D. The effect of alcohol on the risk of lung cancer in Uruguay. Cancer Epidemiol. Biomark. Prev., 2: 21-26, 1993.
8. Dosemeci, M., Gokmen, I., Unsal, M., Hayes, R. B., and Blair, A. Tobacco, alcohol use, and risks of laryngeal and lung cancer by subsite and histologic type in Turkey. Cancer Causes Control, 8: 729-737, 1997.
9. Vogelstein, B., and Kinzler, K. W. Carcinogens leave fingerprints. Nature (Lond.), 355: 209-210, 1992.
10. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
11. Puisieux, A., Lim, S., Groopman, J., and Ozturk, M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res., 51: 6185-6189, 1991.
12. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science (Washington DC), 274: 430-432, 1996.
13. Brennan, J. A., Boyle, J. O., Koch, W. M., Goodman, S. N., Hruban, H. R., Eby, Y. J., Couch, M. J., Forastiere, A. A., and Sidransky, D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332: 712-717, 1995.
14. Field, J. K., Spandidos, D. A., and Stell, P. M. Overexpression of p53 gene in head-and-neck cancer, linked with heavy smoking and drinking. Lancet, 339: 502-503, 1992.
15. Mountain, C. F. Revisions in the International System for Staging Lung Cancer. Chest, 111: 1710-1717, 1997.
16. Sidransky, D., Von Eschenbach, A., and Tsai, Y. C. Identification of p53 mutations in bladder cancers and urine samples. Science (Washington DC), 252: 706-709, 1991.
17. Ahrendt, S. A., Halachmi, S., Chow, J. T., Wu, L., Halachmi, N., Yang, S. C., Wehage, S., Jen, J., and Sidransky, D. Rapid p53 sequence analysis using an oligonucleolide probe array in primary lung cancer. Proc. Natl. Acad. Sci. USA, 96: 7382-7387, 1999.
18. Anderson, L. M., Chabra, S. K. Nerurkar, P. V., Souliotis, L. V., and Kyrtopoulos, S. A. Alcohol-related cancer risk: a toxicokinetic hypothesis. Alcohol. 12: 97-104, 1995.
19. Grafstrom, R. C., Dypbukt, J. M., Sundqvist, K., Atzori, L., Nielsen, I., Curren, R. D., and Harris, C. C. Pathobiological effects of acetaldehyde in cultured human epithelial cells and fibroblasts. Carcinogcnesis (Lond.), 15: 985-990, 1994.
20. Kondo, K., Tsuzuki, H., Sasa, M., Sumitomo, M., Uyama, T., and Monden, Y. A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients. J. Surg. Oncol., 61: 20-26, 1996.
21. Westra, W. H., Offerhaus, J. A., Goodman, S. N., Slebos, R. J. C., Polak, M., Baas, I. O., Rodenhuis, S., and Hruban, R. H. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am. J. Surg. Pathol., 17: 213-220, 1993.
22. Bongiorno, P. F., Whyte, R. I., Lesser, E. J., Moore, J. H., Orringer, M. B., and Beer, D. G. Alterations of K-ras, p53, and erhB-2/neu in human lung adenocarcinomas. J. Thorac. Cardiovasc. Surg., 107: 590-595, 1994.
23. Liloglou, T., Ross, H., Prime, W., Donnelly, R. J., Spandidos, D. A., Gosney, J. R., and Field, J. K. p53 gene aberrations in non-small cell lung carcinomas from a smoking population. Br. J. Cancer, 75: 1119-1124, 1997.
24. Suzuki, H., Takahashi, T., Kuroishi, T., Suyama, M., Ariyoshi, Y., Takahashi, T., and Ueda, R. Mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res., 52: 734-736, 1992.
25. Husgafvel-Pursiainen, K., and Kannio, A. Cigarette smoking and p53 mutations in lung cancer and bladder cancer. Eniviron. Health Perspect., 104 (Suppl. 3): 553-556, 1996.
26. Wang, X., Christiani, D. C., Wiencke, J. K., Fischbein, M., Xu, X., Cheng, T. J., Mark, E., Wain, J. C., and Kelsey, K. T. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol. Biomark. Prev., 4: 543-548, 1995.
27. Marchetti, A., Pellegrini, S., Sozzi, G., Bertacca, G., Gaeta, P., Buttitta, F., Carnicelli, V., Griseri, P., Chella, A., Angeletti, C. A., Pierotti, M., and Bevilacqua, G. Analysis of lung tumors of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus. Br. J. Cancer, 78: 73-78, 1998.
28. Ryberg, D., Kure, E., Lystad, S., Skaug, V., Stangeland, L., Mercy, I., Borresen, A. L., and Haugen, A. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res., 54: 1551-1555, 1994.
29. Chiba, I., Takahashi, T., Nau, M., D'Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D. L., Carbone, D., Piantadosi, S., Koga, H., Reissman, P. T., Slamon, D. J., Holmes, E. C., and Minna, J. D. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
30. Chen, J. X., Zheng, Y., West, M., and Tang, M. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res., 58: 2070-2075. 1998.
31. Denissenko, M. F., Pao, A., Pfeifer, G. P., and Tang, M. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene. 16: 1241-1247, 1998.
32. Brownson, R. C., Loy, T. S., Ingram, E., Myers, J. L., Alavanja, M. C., Sharp, D. J., and Chang, J. C. Lung cancer in nonsmoking women: histology and survival patterns. Cancer (Phila.), 75: 29-33, 1995.
33. Sozzi, G., Sard, L., De Gregorio, L., Marchetti, A., Musso, K., Bultitta, F., Tornielli, S., Pellegrini, S., Veronesi, M. L., Manenti, G., Incarbone, M., Chella, A., Angeletti, C. A., Patorino, U., Huebner, K., Bevilacqua, G., Pilotti, S., Croce, C. M., and Pierotti, M. A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res., 57: 2121-2123, 1997.
34. Rusch, V., Klimstra, D., Linkov, I., and Dmitrovsky, E. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia, and coexpression precedes squamous cell carcinoma development. Cancer Res., 55: 1365-1372, 1995.
35. Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T., Nakanishi, R., and Shirakusa, T. Mutations of the p53 gene as a predictor of poor prognosis in patienls with non-small-cell lung cancer. J. Natl. Cancer Inst., 85: 2018-2023, 1993.